The first inhaled insulin, Pfizer’s Exubera, was approved by the FDA in 2006. It was ultimately removed from the market a year later due to poor sales. In theory, the lungs are an excellent site for insulin delivery due to ...
- The Future is Now: How Personalized Medicine is Changing the Game in Healthcare
- Empowering Patients: How Value-Based Care Puts Your Health at the Center
- The Science Behind GLP-1s and Their Impact on Obesity: Everything You Need to Understand
- Breaking Barriers: New and Effective Solutions for the Healthcare Staffing Crisis
- Breaking the Mold: Unconventional Strategies for Addressing the Healthcare Worker Shortage
